Conflicting results have been reported on the association between restriction fragment length polymorphisms (RFLPs) at the vitamin D receptor O R ) gene locus (i.e., for BsmI, ApaI, and TuqI) and bone mineral density (BMD). We analyzed this association in a large population-based sample (n = 1782) of men and women aged 55-80 years using a novel direct haplotyping polymerase chain reaction (PCR) test to monitor the three polymorphic sites simultaneously. The direct haplotyping test we developed demonstrated a larger degree of genetic polymorphism at the VDR gene locus than described until now. None of the individual RFLPs were associated with BMD at the proximal femur. By analyzing allele dose effects, we identified a VDR haplotype allele weakly associated with low BMD. This allele, as one representative of the group of b alleles, is different from the BsmI allele previously reported by other groups to be associated with low BMD. This suggests allelic heterogeneity at the VDR locus in relation to BMD. Our results indicate at most a small effect of the VDR genotype on BMD in this elderly population. Since anonymous polymorphisms were analyzed, alternative explanations for our results include linkage to another nearby bone-metabolism related gene. (J Bone Miner Res 19961 1A241-1248)
INTRODUCTION
STEOPOROS~S is characterized by low bone mineral den-0 sity (BMD) and microarchitectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fracture. U p to 75% of variation in BMD has been suggested to be determined by genetic factors.("') Recent studies have demonstrated a genetic association between the vitamin D receptor (VDR) gene locus and BMD in Caucasian,("" Japanese,") and black women.(x) Other *PartS of this work were presented as an abstract at the XXIVth European Symposium on Calcified Tissues on May 27-30, 1995, in Aarhus, Denmark, and at the 17th annual meeting of the American Society for Bone and Mineral Research on September 9-13, 1995, in Baltimore, Maryland, U.S.A. studies of similar size, however, could not corroborate these findings.("-") There may be several explanations for the discrepancy between these studies.(I3) First, the sample size and consequently the statistical power of the previous studies was limited. Second, there may have been bias, e.g., due to population admixture in studies, suggesting an association. Third, linkage disequilibrium may exist, e.g., the VDR gene locus itself may not be causally related to BMD but is linked to a neighboring bone-metabolism related gene. Because recombination between the VDR gene and the putative bone-metabolism related gene may occur at each meiosis, linkage disequilibrium may be found in some populations but not in others. Fourth, there may be allelic heterogeneity, i.e., the VDR gene may be implicated in BMD, but different gene variants are associated with BMD in different populations. The lack of association can then be 'Department of Internal Medicine 111, Erasmus University Medical School, Rotterdam, The Netherlands. 'Department of Epidemiology & Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
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explained by the fact that a given polymorphism is not testing for the VDR gene variant in a particular population and by using less informative genetic markers.
To address these problems, we have analyzed in a large population-based sample from the Rotterdam Study"" the association between VDR genotype and BMD of the proximal femur. The power o f an association study can be increased when informative, multiallelic markers are used.
Thc marker mostly analyzed so far in relation to BMD is a n anonymous intronic restriction fragment length polymorphism for BsrnI between exons 7 and 8 of the VDR gene.'-3' This marker discriminates only two alleles combining to three genotypcs. For our study, we developed a genetically more informative direct haplotyping PCR test to monitor three clustered anonymous restriction site polymorphism at the VDR gene locus simultaneously. Preliminary re-1.5.1(,) using this novel genotyping method suggested a considerable effect of VDR genotype on BMD in our population. To increase further the statistical power of our study, we expanded the number of individuals to include 880 men and YO2 women.
MATERIALS AND METHODS

Siihjects
The Kotterdam Study is a prospective population-based cohort study of determinants and prognosis of chronic diseases in the elderly.'14' Eligible for the study were all inhabitants aged 55 years or over of the district of Ommoord in Rotterdam, The Netherlands. A total of 10,275 persons, of whom 9 I61 (89%) were living independently, were invited for the study. In the independently living population, the overall response rate was 77% for the home interview and 71% for the examination in the research centre. Written informcd consent was obtained from each participant. The Rotterdam Study has been approved by the Medical Ethics Committee of Erasmus University Medical School. Thc analysis of the association between VDR genotype and BMD was performed in a sample from the Rotterdam Study. From all 5931 independently living participants with bone density measurements, 1453 subjects were excluded according t o the following criteria: older than 80 years, use of ii walking aid, known diabetes, or use of cytostatics, thyroid hormone, or diuretics. From the 4478 remaining subjects, an age-stratified random sample of 1000 men and 1000 women was drawn with balanced numbers (200) in 5-year age categories. VDR genotyping data and bone density measurements of 880 men and 902 women were available for analysis.
Geriotypirig procedure
Three anonymous polymorphic restriction enzyme recognition sites at the 3' end o f the VDR gene, ix., B.snz1, Apul, and TuqI,("~"') were assessed individually and in relation to each other by a direct haplotyping polymerase chain reaction (PCR) procedure which wc developed. The direct haplotyping procedure is schematically depicted in Fig. la Digestion products were analyzed on a I .4% agarose gel run in 0.5X TBE ( I X TBE = 8Y mM Tris, 89 mM boric acid, 2 mM Na2EDTA) for 250 volt hours (Vh). Separation patterns were documented by Polaroid photography under UV-illumination (302 nm). The alleles were named similarly as previously described for alleles defined by individual RFLPS"~.'"': in genotypes such as BAt-baT, capital letters denote absence and lowercase letters the presence of the site for the restriction enzymes BsniI (Bib), A p l (Aia), and TuqI (Tit) on each of the alleles.
To monitor complete digestion of the PCR products for each of the restriction enzymes used, the fragments indicated with b, aT, and t in Fig. Ib are used. The b fragment of 6.50 bp will only appear for those haplotypes carrying a BsmI recognition site (Fig. la) , the t fragment o f 202 bp will appear only for those haplotypes carrying a T u~I recognition site, while the aT fragment will only appear for those haplotypes carrying an Apul recognition site but no TuqI recognition site. A technical problem that we initially encountered in this genotyping procedure was thc occurrence of heteroduplex molecules (in which the + and -strands of heterologous alleles are basc-pairing) which cannot be digested. By controlling the yield of the PCR amplification (e.g., by performing less cycles), this problem was effectively eliminated. To assess correspondence between the novel haplotyping procedure and the genotyping procedures for determining single restriction sites,".4' we analyzed 200 randomly selected DNA samples by both procedures.
Bori e min era I densi f y m easu remen t BMD (in dcm') at the femoral neck and Ward's triangle
The BMD data are presented as means 5 standard dewas determined by dual-energy X-ray absorptiometry viation (SD) or with 9574 confidence intervals (95% CI). Numbers above the lanes refer to genotypes described in Table 4 . General characteristics of the population are presented in Table I . Allele and genotype frequencies for the BsmI restriction fragment length polymorphism (RFLP) are shown in Table 2 . We first analyzed the association between BMD and VDR genotype defined by the BsniI restriction site polymorphism (Table 3) . Although in women the BB genotype had a slightly higher BMD, no significant differences were observed between genotype groups in either men or women for the femoral neck nor for the Ward's triangle. Allele copy number of the B or b allele was not significantly related to BMD. No differences in mean BMD levels for different ApaI and TuqI genotypes were observed (data not shown).
Butse line
Values arc means t SD.
Comparison of genotyping results obtained by analysis o f single RFLPs and haplotypes showed no discrepancies. When the total population was analyzed using the direct haplotyping procedure, we identified five different alleles at the VDR gene locus coded I to 5 by decreasing frequency. The haplotypes combined to 12 different genotypes (Fig. lb) , of which the frequencies are presented in Table 4 . There were no significant differences in allele frcquencics between men and women. At the haplotype level there is a 99% concordance between b and '1 (and B and t). N o significant departures from Hardy-Weinberg equilibrium were observed for each of the three RFLPs separately nor for the haplotypes. Heterozygosity was 45.5% for the BsmI RFLP and 56.7% for VDR alleles defined by haplotypes.
Mean BMD values at the proximal femur of women and men in relation to VDR genotypes, as assessed by the direct haplotyping procedure, are shown in Table 5 . Differences in mean BMD at the femoral neck and the Ward's triangle could be observed among VDR genotypes in men and women, although none reached significance. In men the [1, 3] , [2, 3] , and [3, 3] had a BMD lower than the population average, whereas in women the [2,2] had a slightly higher BMD and the [3, 3] a lower BMD. The difference in BMD between extreme genotypes in women was 7.3% (corresponding to 0.5 SD) of the highest BMD at the femoral neck and 9.7% (0.5 SD) at the Ward's triangle, while in men this was 4.5% (0.3 SD) and 4.7% (0.2 SD), respectively. The VDR haplotype allele dose effect is shown in Table 6 ; the BMD at the femoral neck decreased by 0.014 g/cmz per copy for allele 3 (= bAT). This allele dose effect was significant in the total population ( p = 0.04), most notably in men ( p = 0.06), while similar but not significant in women ( p = 0.29). A similar but nonsignificant allele dose effect of allele 3 on BMD was observed at the Ward's triangle. When the analysis of allele dose effect was agestratified (above and below the median age of 67 years), we observed for allele 3 a stronger dose effect in women 55-67 years of age (-0.019 g/cm' [95% CI, -0.044-0.007; p = 0.151) compared with women 67-80 years of age (-0.002 gicm' [95% CI, -0.026-0.023; p = 0.911). For men, no relation of allele dose with age was found.
Comparison of allele frequencies in the lowest and highest BMD quintile of the population (cut off value for the lowest quintile is 0.764 g/cm2 for men and 0.698 g/cm2 for women, and in the highest quintile 0.987 gkm' for men and 0.913 gicm' for women) revealed no differences for alleles 1 and 2. Allele 3 had a higher frequency in the lowest quintile (13.4% for men and 13.1% for women) compared with the frequency in the highest quintile (10.7% for men and 8.9% for women; p = 0.12 for men and p < 0.01 for women).
In a large ethnically homogeneous population-based sample, we studied the association between BMD measured at the proximal femur and VDR genotype. While we did not detect an association between individual RFLPs and BMD, the results suggest a weak association between BMD and VDR genotype as measured by direct haplotyping, with a similar trend in men and women. In women, the differences in BMD between extreme genotypes (i.e., the rare [3, 3] and the more common [2, 2] genotype) amounted up to 0.5 SD both at the femoral neck and at the Ward's triangle, while in men this difference was up to 0.3 SD. We previously reported larger differences in a smaller number (n = 800) of individuals from this population.(".lh' This imprecision in estimating mean BMD levels per genotype group probably is a result of low numbers per group. In the latter case, the likelihood of overestimating the magnitude of an association is considerable. An increase in the number of genotypes (because of increased genetic resolution) requires a concommittant increase in sample size to achieve stable and precise point estimates. Because the numbers of individuals per genotype group have now increased considerably, we consider the current estimates to be more reliable and conclude that the VDR genotype has a small effect on BMD in this elderly population.
The increased genetic resolution obtained by direct haplotyping of all three polymorphic sites allowed five different allelic variants of the VDR gene to be discriminated, of which three are common. A genetically meaningful and efficient way to study genotype effects on BMD is to analyze allele dose effects. When the trend among genotypes was analyzed with respect to allele dose, we found the 3 allele (i.e., bAT) to be associated with low BMD. In keeping with these results, we found the allele 3 to be overrepresented in the lowest BMD quintile. In men, the allele dose effect was additive, with the homozygous [3, 3] having a lower BMD than the heterozygous [1, 3] and [2, 3] , which in turn have a BMD lower than that of individuals not carrying allele 3. In women, the heterozygote effect is blurred, perhaps by the influence of determinants of BMD other than VDR, e.g., estrogen status.
When the analysis is limited to only the BsmI site, the five existing haplotype alleles are combined to two alleles (B and b). In our study, no allele dose effect of BsmI alleles could be observed. This is substantiated by the fact that the [1, 1] genotype has a high mean BMD level at the femoral neck in women and the [3, 3] the lowest mean BMD, while both are homozygous bb. We also observed similar trends both in men and women using the haplotype analysis, while no effect on BMD was seen with the individual polymorphisms. Therefore, low genetic resolution can obscure an association between the BMD level and VDR genotypes in studies using individual restriction enzyme recognition site polymorphi~ms.("-'~)
We observed frequencies of the two alleles for the BsmI polymorphism that are almost identical to those of other studies in Caucasians. ('~h,"-12 ) Surprisingly, however, the particular VDR haplotype allele we found associated with * n = number of individuals.
low BMD values is different from the one reported earlier.
According to previous studies,('-x) the b allele was associated with a high BMD level and the B allele with a low BMD level. In contrast, we find the bAT haplotype allele (as one representative of the group of b alleles) to be associated with low BMD. In this respect, it should be noted that a study in Scotland has recently also demonstrated an association of the b allele with low BMD.('") Our results together with those of others indicate that there is either allelic heterogeneity at the VDR locus among different populations or linkage disequilibrium with another bone metabolism-related gene. In the latter case, the difference in the direction of the genetic effect (i.e., which allele is associated with either low or high BMD) can be explained by a recombination which has occurred between the VDR gene and the putative bone metabolism-related gene in our study population. Alternatively, in the case of allelic heterogeneity, it is expected that differences in biological effect and direction of the genetic effect might be accompanied by differences in haplotype distributions among different populations. Arguing against allelic heterogeneity in this respect is the fact that haplotype frequencies in a Japanese age-and BMI-adjusted; the Y5% CI is presented in brackets. population'*" and an Australian population,(") although inferred and not determined directly, are very different, but they show the same VDR allele being associated with high BMD. In addition, haplotype frequencies in the Australian population and our population are similar, but different VDR alleles are associated with low BMD. The direction of a genetic effect, however, can also be influenced by geneenvironment interactions. Allelic heterogeneity could thus be explained as different alleles having the same effect in different populations due to differences in environment. Environmental influences such as Calcium (Ca) intake are known to differ widely between populations(22) and have been shown to contribute to the genetic effect of VDR genotype on BMD'" and on rates of bone loss.(2" However, in a preliminary analysis of dietary Ca intake in relation to BMD and VDR genotype in our population, which has a relatively high Ca intake (mean is 1139 and 1093 mgiday in men and women, respectively), we observed that the small effect of dietary Ca intake on BMD was not strongly VDR genotype-dependent (data not shown). An analysis of the relationship between the VDR genotype, Ca intake, BMD, and rates of loss is now under way.
In the absence of knowledge on functional sequence variations in the VDR gene in linkage with the three polymorphisms described so far, neither allelic heterogeneity nor linkage disequilibrium with another bone metabolismrelated gene can be excluded as an explanation for the different direction and magnitude of the genetic effect of VDR genotype on BMD between different studies. In this respect, a more comprehensive analysis of sequence variation in functionally relevant parts of the VDR locus but also in its direct chromosomal vicinity will help to make a distinction. It should be noted that other examples of one allele having different genetic effects are known to occur. For example, in the case of the association between ApoE alleles and early onset Alzheimers disease (EOAD), some studies showed a protective effect of the E2 allele while others demonstrated an increased risk of EOAD for ApoE2 carriers.(24' Also in this case, possible explanations for the opposite genetic effect are along the lines described above.
Finally, differences between VDR genotypes in BMD levels could reflect differences in peak bone mass as obtained in young adulthood and/or be due to differences in age-related bone loss. Preliminary follow-up data from our population (mean follow-up time 2.4 years) indicate that a high BMD is not due to a lower rate of bone loss (data not shown). This at least suggests that subjects with VDR genotypes characterized by a low BMD level are apparently not fast bone losers. In this respect, it should be noted that in an elderly population the VDR genotype effect on BMD can be attenuated by other determinants of BMD such as life-style factors, including diet and mobility. A role of VDR genotype in determining peak bone mass can therefore not be excluded.
In conclusion, we found a weak association between VDR genotype and BMD. The increased genetic resolution allowed us to identify an allele associated with low BMD, which is different from the one found previously by other groups. Neither allelic heterogeneity of the VDR gene nor linkage disequilibrium of the VDR locus with another bone metabolism-related gene can be excluded to explain the differences in direction of the genetic effect between our study and other studies. Based on current evidence, it appears likely that the differences in bone mass between the different genotypes are obtained early in life rather than due to age-related bone loss. Studies of the association of VDR genotype with peak bone mass in younger individuals will help to clarify this issue.
